Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?

ABSTRACT: Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients' state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depressio

SUBMITTER: Harsanyi S 

PROVIDER: S-EPMC9820159 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature